Profile | GDS5420 / 213290_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 174.3 | 50 |
GSM1296119 | B_lesional_pre-dose | 287.96 | 58 |
GSM1296076 | C_lesional_pre-dose | 334.21 | 62 |
GSM1296092 | D_lesional_pre-dose | 358.12 | 63 |
GSM1296103 | E_lesional_pre-dose | 211.4 | 53 |
GSM1296078 | F_lesional_pre-dose | 369.82 | 64 |
GSM1296107 | G_lesional_pre-dose | 316.35 | 60 |
GSM1296109 | H_lesional_pre-dose | 307.66 | 59 |
GSM1296080 | I_lesional_pre-dose | 198.64 | 53 |
GSM1296090 | J_lesional_pre-dose | 980.03 | 79 |
GSM1296074 | K_lesional_pre-dose | 250.07 | 58 |
GSM1296111 | L_lesional_pre-dose | 345.89 | 61 |
GSM1296099 | M_lesional_pre-dose | 312.99 | 59 |
GSM1296086 | O_lesional_pre-dose | 323.08 | 61 |
GSM1296117 | P_lesional_pre-dose | 273.82 | 57 |
GSM1296113 | Q_lesional_pre-dose | 356.92 | 61 |
GSM1296096 | R_lesional_pre-dose | 219.99 | 54 |
GSM1296105 | S_lesional_pre-dose | 655.81 | 72 |
GSM1296098 | T_lesional_pre-dose | 141.98 | 46 |
GSM1296101 | U_lesional_pre-dose | 650.52 | 72 |
GSM1296121 | V_lesional_pre-dose | 264.07 | 57 |
GSM1296088 | W_lesional_pre-dose | 452.16 | 66 |
GSM1296082 | X_lesional_pre-dose | 285.08 | 60 |
GSM1296115 | Y_lesional_pre-dose | 316.61 | 60 |
GSM1296084 | Z_lesional_pre-dose | 557.37 | 70 |
GSM1296072 | B_lesional_day8 | 332.11 | 60 |
GSM1296069 | L_lesional_day8 | 677.13 | 73 |
GSM1296071 | P_lesional_day8 | 775.12 | 75 |
GSM1296070 | Y_lesional_day8 | 703.14 | 73 |
GSM1296073 | V_lesional_day8 | 253.16 | 57 |
GSM1296034 | A_lesional_day15 | 401.58 | 63 |
GSM1296041 | G_lesional_day15 | 235.25 | 55 |
GSM1296035 | R_lesional_day15 | 420.87 | 64 |
GSM1296038 | U_lesional_day15 | 632.52 | 72 |
GSM1296047 | B_lesional_day15 | 371.78 | 62 |
GSM1296039 | E_lesional_day15 | 305.53 | 60 |
GSM1296042 | H_lesional_day15 | 528.8 | 69 |
GSM1296043 | L_lesional_day15 | 760.04 | 75 |
GSM1296037 | M_lesional_day15 | 780.34 | 75 |
GSM1296046 | P_lesional_day15 | 519.33 | 68 |
GSM1296044 | Q_lesional_day15 | 664.21 | 72 |
GSM1296045 | Y_lesional_day15 | 907.35 | 78 |
GSM1296025 | C_lesional_day15 | 458.87 | 66 |
GSM1296033 | D_lesional_day15 | 545.25 | 69 |
GSM1296027 | I_lesional_day15 | 734.36 | 74 |
GSM1296032 | J_lesional_day15 | 855.08 | 76 |
GSM1296024 | K_lesional_day15 | 492.86 | 67 |
GSM1296031 | W_lesional_day15 | 1017.12 | 79 |
GSM1296028 | X_lesional_day15 | 770.87 | 75 |
GSM1296029 | Z_lesional_day15 | 1307.05 | 83 |
GSM1296026 | F_lesional_day15 | 864.88 | 77 |
GSM1296030 | O_lesional_day15 | 368.14 | 63 |
GSM1296040 | S_lesional_day15 | 592.91 | 70 |
GSM1296036 | T_lesional_day15 | 217.14 | 53 |
GSM1296048 | V_lesional_day15 | 545.28 | 69 |
GSM1296059 | A_lesional_day43 | 647.1 | 72 |
GSM1296066 | G_lesional_day43 | 277.54 | 57 |
GSM1296060 | R_lesional_day43 | 283.71 | 58 |
GSM1296063 | U_lesional_day43 | 602.54 | 71 |
GSM1296064 | E_lesional_day43 | 282.54 | 59 |
GSM1296067 | H_lesional_day43 | 732.48 | 74 |
GSM1296062 | M_lesional_day43 | 237.78 | 55 |
GSM1296068 | Q_lesional_day43 | 761.34 | 75 |
GSM1296050 | C_lesional_day43 | 741.86 | 74 |
GSM1296057 | D_lesional_day43 | 664.21 | 72 |
GSM1296052 | I_lesional_day43 | 835.23 | 76 |
GSM1296054 | J_lesional_day43 | 870.64 | 77 |
GSM1296049 | K_lesional_day43 | 467.69 | 67 |
GSM1296055 | W_lesional_day43 | 1066.69 | 80 |
GSM1296053 | X_lesional_day43 | 794.11 | 75 |
GSM1296058 | Z_lesional_day43 | 1891.56 | 88 |
GSM1296051 | F_lesional_day43 | 719.65 | 74 |
GSM1296056 | O_lesional_day43 | 353.77 | 62 |
GSM1296065 | S_lesional_day43 | 590.98 | 70 |
GSM1296061 | T_lesional_day43 | 289.3 | 58 |
GSM1296095 | A_non-lesional_pre-dose | 479.03 | 67 |
GSM1296120 | B_non-lesional_pre-dose | 379.68 | 63 |
GSM1296077 | C_non-lesional_pre-dose | 597.67 | 71 |
GSM1296093 | D_non-lesional_pre-dose | 410.46 | 64 |
GSM1296104 | E_non-lesional_pre-dose | 473.76 | 67 |
GSM1296079 | F_non-lesional_pre-dose | 648.29 | 72 |
GSM1296108 | G_non-lesional_pre-dose | 569.76 | 70 |
GSM1296110 | H_non-lesional_pre-dose | 630 | 71 |
GSM1296081 | I_non-lesional_pre-dose | 955.53 | 78 |
GSM1296091 | J_non-lesional_pre-dose | 526.37 | 69 |
GSM1296075 | K_non-lesional_pre-dose | 488.66 | 68 |
GSM1296112 | L_non-lesional_pre-dose | 736.04 | 74 |
GSM1296100 | M_non-lesional_pre-dose | 489.65 | 67 |
GSM1296087 | O_non-lesional_pre-dose | 523.06 | 69 |
GSM1296118 | P_non-lesional_pre-dose | 374.38 | 62 |
GSM1296114 | Q_non-lesional_pre-dose | 579.99 | 70 |
GSM1296097 | R_non-lesional_pre-dose | 576.48 | 70 |
GSM1296106 | S_non-lesional_pre-dose | 614.95 | 71 |
GSM1296102 | U_non-lesional_pre-dose | 1004.6 | 79 |
GSM1296122 | V_non-lesional_pre-dose | 506.74 | 68 |
GSM1296089 | W_non-lesional_pre-dose | 1283.97 | 83 |
GSM1296083 | X_non-lesional_pre-dose | 1063.95 | 80 |
GSM1296116 | Y_non-lesional_pre-dose | 575.63 | 70 |
GSM1296085 | Z_non-lesional_pre-dose | 798.09 | 75 |